Moderna, Inc.
mRNA-1010
seasonal influenza vaccine
Resolved
192days ago
FDA decision · Feb 10, 2026
What's at stake
An FDA complete response letter on mRNA-1010 for seasonal influenza vaccine is in focus around Feb 10, 2026.
Primary source
· SEC 8-K
verified 2mo ago
“The U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has notified the Company that it will not initiate a review of the biologics license application (BLA) for its investigational influenza vacci”